FBXW2 and atherosclerosis: In conclusion, our study identified FBXW2 as a negative regulator of KSRP, which drives the mRNA instability of proinflammatory genes and leads to inflammatory responses in macrophages during obesity‐associated insulin resistance and atherosclerosis.